Nelson Labs Expands Lab Operations and Testing Capabilities

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletterPharmaceutical Technology\'s In the Lab eNewsletter-05-02-2018
Volume 13
Issue 5

The company doubled capacity for laboratory services at its facility in Itasca, IL.

Nelson Laboratories announced on April 19, 2018 that it has invested in expansions of operations and service capabilities at the its laboratory facility in Itasca, IL.

The 10,000-square-foot expansion houses upgrades that include renovated lab space and a biological indicator sterility suite to support ethylene oxide sterilization validations. The company has expanded its test offerings to include more than double the capacity for bioburden, radiation sterilization validations, bacterial endotoxin testing, and product sterility testing for medical devices and pharmaceutical products.

New testing capabilities include medical device particulate testing, healthcare reprocessing validations, sterilization for reuse validations, and genetic microbial identification testing. These capabilities will be fully operational beginning May 1, 2018. 

According to the company, its Itasca laboratory facility is now International Organization for Standardization 17025-accredited and adheres to the same quality system as the company’s global headquarters in Salt Lake City, UT. Additionally, clients are now able to track their submitted studies and retrieve test reports via the company’s secure customer portal.

“Our customers will benefit from our enhanced quality system and expanded services, as well as the unparalleled expertise and customer service they have come to trust from Nelson Labs,” said John S. Bolinder, vice president of North American lab operations at Nelson Labs, in a company press release. “In addition, we are able to offer the leading sterilization services of our sister company, Sterigenics, at multiple facilities located within close proximity to our Itasca laboratory. This allows us to more fully serve the needs of our sterilization and laboratory customers throughout the Midwestern region of the United States.”

Source: Nelson Labs

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content